Equillium, Inc. (LON:0A4D)

London · Delayed Price · Currency is GBP · Price in USD

2.230

+0.020 (0.90%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	41.10M	36.08M	15.76M	-	-
Pharmaceuticals Growth	13.89%	128.97%	-	-	-
Total	41.10M	36.08M	15.76M	-	-
Total Growth	13.89%	128.97%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	41.10M	36.08M	15.76M	-	-
United States Growth	13.89%	128.97%	-	-	-
Total	41.10M	36.08M	15.76M	-	-
Total Growth	13.89%	128.97%	-	-	-

Source: S&P Global Market Intelligence.